August 21, 2019
Don’t question your logic … as to your continued investot complacency versus trader's sandbox antics
Liquidity remains a cause for concern
A looking for a few bounces to the upside but, again who and where are the buyers?
August 19, 2019
Share pricing is down -$0.01 to $0.98
Pricing of $57.5 M offering of preferred stock and warrants and entry into concurrent Private Placement of up to $70 MM and $12.1 M "Upfront Option Fee"
August 20, 2019
Monday, I stated to SELL into strength worried about pricing’s sustainability
Pre-open indications: 6 HITs and 3 MISS <I’m sticking by my two (2) undervalued>
What’s wrong with be right so often?
“Venimus nos emit et vendidit nos rursus” – “We have bought and sold again". That's why today's not a good day for all who owned cell and gene therapy equities to reassess?
August 5, 2019
A scorecard of earnings of 45 covered companies The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"
August 5, 2019
Volatility, algorithms, sustainability … but, geopolitical ssues are "trumping" the news Add to the list, trend analysis, momentum’s magnitude, technicals and fundamentals – do they indicate expected pricing performance in 2019? Why spend time finding sector news and analytics … it’s all right here! News has become "something" sold into
May 19, 2019
A scorecard of earnings of 45 covered companies 41 so far: 2 acquired (AST, OSIR) 1 on acquisition hold - ONCE) and 1 set to be reversed (HSGX) ... The current LPS (loss per share) or net income, cash positions i.e. "runways" - is a reflection of this universe's investing "status"
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.